Hanmi Science reports Q1 operating profit of 27 billion won, down 27.4% year-on-year, despite 3.8% increase in sales to 332.1 billion won
#YonhapInfomax #HanmiScience #Q1Earnings #OperatingProfit #YearOnYearDecrease #SalesGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60470

HanmiScience reports significant decline in Q1 operating profit, reflecting challenging market conditions in pharmaceutical sector
#YonhapInfomax #HanmiScience #Q1Earnings #OperatingProfit #YearOnYearDecline #PharmaceuticalSector #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60469

La Defense Partners aims to enhance Hanmi Science's governance transparency and maximize shareholder value, purchasing additional shares amid recent stock price decline.
#YonhapInfomax #LaDefensePartners #HanmiScience #CorporateGovernance #ShareholderValue #StockPurchase #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59188

Hanmi Science CEO Kim Jae-gyo announces focus on innovative global drug development, restructures organization to enhance strategic growth and innovation capabilities
#YonhapInfomax #HanmiScience #GlobalNewDrugs #PharmaceuticalIndustry #OrganizationalRestructuring #InnovationStrategy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56769

Hanmi Pharmaceutical Group transitions to professional management as Chairwoman Young-Sook Song resigns from holding company leadership, marking a new era for the Korean pharmaceutical giant.
#YonhapInfomax #HanmiPharmaceuticalGroup #ProfessionalManagement #YoungSookSong #HanmiScience #LeadershipTransition #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=55745

Hanmi Science appoints Chairwoman Song Young-sook as new CEO, signaling end to year-long management dispute and focus on organizational stability and business normalization
#YonhapInfomax #HanmiScience #CEOAppointment #ManagementDispute #BoardRestructuring #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=50792